An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.
Also called NCT03216564
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 320 participants
- Registry
-
NCT03216564
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Qatar
- Registry status
- Unknown status
Technical summary
Registry record NCT03216564. Randomized; single masking; primary purpose treatment. Start 2017-05-10 (actual); primary completion 2019-05-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes
- Acronym
- IDEAL-2
- Condition
- Diabetic Nephropathies
- Intervention (Drug)
- Calcitriol
- Lead sponsor
- Hamad Medical Corporation
- Collaborator
- Weill Cornell Medical College in Qatar
Record details
- Record id
cardio:ct-nct03216564- Content hash
51dada19d5929b0440fc6eaadd0fb49053f0fc748a9b06e522d3c04c18d8d5be